Repligen (FRA:RGN) Inventories, Finished Goods : €53.7 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Repligen Inventories, Finished Goods?

Repligen's quarterly finished goods declined from Jun. 2024 (€68.6 Mil) to Sep. 2024 (€62.0 Mil) and declined from Sep. 2024 (€62.0 Mil) to Dec. 2024 (€53.7 Mil).

Repligen's annual finished goods declined from Dec. 2022 (€78.0 Mil) to Dec. 2023 (€68.1 Mil) and declined from Dec. 2023 (€68.1 Mil) to Dec. 2024 (€53.7 Mil).

Repligen Inventories, Finished Goods Historical Data

The historical data trend for Repligen's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Repligen Inventories, Finished Goods Chart

Repligen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Inventories, Finished Goods

Get a 7-Day Free Trial

31.40

46.95

78.03

68.07

53.68

Repligen Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Inventories, Finished Goods	Get a 7-Day Free Trial															68.07	68.25	68.55	62.01	53.68

Repligen Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Repligen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Repligen Corp (FRA:RGN) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

RGEN:USA RGN:Germany

Address

41 Seyon Street, Building 1, Suite 100, Waltham, MA, USA, 02453

Website

https://www.repligen.com

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Repligen Headlines

No Headlines